Cyendiv (Nintedanib) Soft Gelatin Capsule is an oral medication that slows the progression of idiopathic pulmonary fibrosis (IPF) and other chronic fibrosing interstitial lung diseases. Moreover, it inhibits specific pathways that contribute to lung tissue scarring, thereby improving patients’ quality of life. For more information, refer to trusted sources such as Mayo Clinic, Drugs.com, FDA, WebMD, PubMed, Healthline, and WHO.

Key Benefits & Uses:

• Slows the progression of idiopathic pulmonary fibrosis (IPF).

• Reduces lung tissue scarring in chronic fibrosing interstitial lung diseases.

• Supports improved respiratory function and enhances quality of life.

• Clinically proven to target multiple pathways involved in fibrosis.

• Additionally, it helps manage long-term lung health as detailed by Mayo Clinic and Drugs.com.

How to Use:
Take Cyendiv exactly as your healthcare provider prescribes. Typically, you should take it orally with water, with or without food, at the same time each day. Therefore, avoid missing doses, and consult your doctor if you require dose adjustments. Detailed usage guidance is available at WebMD and FDA.

Important Safety Information:

• Inform your doctor about any liver, kidney, or heart conditions before starting treatment.

• Consequently, your doctor may monitor liver function regularly.

• Avoid pregnancy while using Cyendiv.

• Moreover, follow comprehensive safety guidelines from Healthline and WHO.

Common Side Effects:

• Diarrhea, nausea, and vomiting.

• Liver enzyme changes.

• Reduced appetite or weight loss.

• If symptoms worsen, consult your healthcare provider immediately. More information is available at PubMed.

Why Choose Cyendiv:
Cyendiv Nintedanib Soft Gelatin Capsule offers a clinically validated solution for managing progressive lung fibrosis. Furthermore, it has a strong safety profile and proven efficacy, which supports better long-term lung health. Trusted medical sources, including Mayo Clinic and FDA, emphasize its benefits for patients with IPF and chronic fibrosing conditions.